Home
Imugene Ltd
FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
Business
Aug 10 2022
4 min read

FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC

news images

Imugene Ltd has released a press release.

View Attachment